eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2022
vol. 39
 
Share:
Share:
more
 
 
abstract:
Original paper

The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up

Piotr Brzezinski
1, 2
,
Uwe Wollina
3
,
Janusz Smigielski
4
,
Katarzyna Borowska
5

1.
Department of Physiotherapy and Medical Emergency, Faculty of Health Sciences, Pomeranian Academy, Slupsk, Poland
2.
Department of Dermatology, Provincial Specialist Hospital in Slupsk, Ustka, Poland
3.
Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany
4.
Social and Technical Department, State University of Applied Sciences, Konin, Poland
5.
Department of Histology and Embryology with Experimental Cytology Unit, Medical University of Lublin, Lublin, Poland
Adv Dermatol Allergol 2022; XXXIX (4): 682-687
Online publish date: 2022/09/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Acne vulgaris is a chronic inflammatory skin disease of the pilosebaceous follicles that affects patients of all ages.

Aim
Use of isotretinoin in the early stages of the disease to prevent subsequent lesions of acne, including prolonged treatment and acne scars at a later age.

Material and methods
A retrospective, comparative study was carried between January 2010 and November 2018. The study population consisted of 90 children aged 9–18 years with acne. During treatment by isotretinoin the clinical evaluation was done every month. Patients were divided into three groups according to age. One of the qualification criteria was follow-up visits.

Results
A total of 90 children (67.8% females; mean age: 13.5 years) were enrolled. In group A (30 individuals – aged 9–11) and B (30 individuals – aged 12–13), treatment was terminated 2 months after clinical improvement (mean: 3 months). In control group C (30 individuals – aged 14–18), treatment was carried out using average cumulative dose 135 mg/kg bw/day. All groups showed up for follow-up. after 1 to 8 years. In groups A and B, 13 people underwent a second acne treatment; in 3.33% oral isotretinoin was used, in 18.33% topical treatment. In group C, 30 (100%) individuals underwent a second acne treatment; in 20% oral isotretinoin was used, and 80% required a topical treatment. Acne scars and post acne hyperpigmentation have been documented in 73.33% in group C.

Conclusions
Early, reasonable and short-term use of isotretinoin can reduce the incidence of acne in the future and reduce the occurrence of secondary acne symptoms.

keywords:

acne, acne treatment, early childhood, isotretinoin, paediatric acne

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.